Jayant Kasturi, Sankaranarayanan Rengaswamy, Thorat Ranjit V, Muwonge Richard, Hingmire Sanjay J, Panse Nandkumar S, Shastri Surendra S, Malvi Sylla G, Nene Bhagwan
Nargis Dutt Memorial Cancer Hospital, Barshi India, India. Email:
Asian Pac J Cancer Prev. 2016 Nov 1;17(11):4837-4844. doi: 10.22034/APJCP.2016.17.11.4837.
Objectives: To describe the survival experience of cervix cancer patients in a screened rural population in India. Methods: Included 558 cervical cancer patients diagnosed in 2000-2013 in a cohort of 100,258 women invited for screening during 2000-2003. The primary end point was death from cervical cancer. We used the Kaplan-Meier method to estimate cumulative observed survival and Cox proportional hazards regression to assess the effect of patient characteristics on survival after diagnosis. Results: Of the 558 cases included, 143 (26%) and 114 (20%) were diagnosed in stages IA and IB respectively; 252 (45.2%) were dead, and 306 (54.8%) were alive at the last follow-up. The overall 5-year observed survival was 60.5%. The 5-year survival of stage IA patients was 95.1% and 5.3% for stage IV patients. All surgically treated stage IA patients, 94.1% of stage IB patients receiving intracavitary radiotherapy, 62% of stage IIB, 49% of stage III and 25% of stage IV patients receiving radiotherapy survived for 5 years. Conclusion: Higher 5-year survival in our study than elsewhere in India is due to the high proportion of early stage cancers detected by screening combined with adequate treatment, resulting into a favourable prognosis.
描述印度农村筛查人群中宫颈癌患者的生存情况。方法:纳入2000 - 2013年诊断的558例宫颈癌患者,这些患者来自2000 - 2003年受邀参加筛查的100258名女性队列。主要终点是死于宫颈癌。我们使用Kaplan-Meier方法估计累积观察生存率,并使用Cox比例风险回归评估患者特征对诊断后生存的影响。结果:在纳入的558例病例中,分别有143例(26%)和114例(20%)在IA期和IB期被诊断;252例(45.2%)死亡,306例(54.8%)在最后一次随访时存活。总体5年观察生存率为60.5%。IA期患者的5年生存率为95.1%,IV期患者为5.3%。所有接受手术治疗的IA期患者、94.1%接受腔内放疗的IB期患者、62%的IIB期患者、49%的III期患者和25%接受放疗的IV期患者存活了5年。结论:我们研究中5年生存率高于印度其他地方,这是由于筛查发现的早期癌症比例高并结合了充分治疗,从而产生了良好的预后。